Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.900
-0.060 (-2.03%)
At close: May 30, 2025, 4:00 PM
3.040
+0.140 (4.83%)
After-hours: May 30, 2025, 4:02 PM EDT
Kalaris Therapeutics Statistics
Total Valuation
KLRS has a market cap or net worth of $54.24 million. The enterprise value is -$46.73 million.
Market Cap | 54.24M |
Enterprise Value | -46.73M |
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KLRS has 18.70 million shares outstanding. The number of shares has increased by 64.52% in one year.
Current Share Class | 18.70M |
Shares Outstanding | 18.70M |
Shares Change (YoY) | +64.52% |
Shares Change (QoQ) | -39.60% |
Owned by Insiders (%) | 6.80% |
Owned by Institutions (%) | 9.12% |
Float | 5.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.85 |
P/TBV Ratio | 0.85 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.31
Current Ratio | 14.31 |
Quick Ratio | 14.14 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.44 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -62.04% |
Revenue Per Employee | n/a |
Profits Per Employee | -$5.43M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.96% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -82.96% |
50-Day Moving Average | 6.02 |
200-Day Moving Average | 11.88 |
Relative Strength Index (RSI) | 24.82 |
Average Volume (20 Days) | 52,364 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -59.52M |
Pretax Income | n/a |
Net Income | -75.96M |
EBITDA | n/a |
EBIT | -59.52M |
Earnings Per Share (EPS) | -$10.39 |
Balance Sheet
The company has $100.97 million in cash and n/a in debt, giving a net cash position of $100.97 million or $5.40 per share.
Cash & Cash Equivalents | 100.97M |
Total Debt | n/a |
Net Cash | 100.97M |
Net Cash Per Share | $5.40 |
Equity (Book Value) | 63.87M |
Book Value Per Share | 3.42 |
Working Capital | 95.04M |
Cash Flow
Operating Cash Flow | -23.59M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KLRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -64.52% |
Shareholder Yield | -64.52% |
Earnings Yield | -140.04% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |